Immunization with High-Dose Intradermal Recombinant Hepatitis B Vaccine in Healthcare Workers Who Failed to Respond to Intramuscular Vaccination
- 1 February 1995
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 16 (2), 88-91
- https://doi.org/10.2307/30140948
Abstract
Objective: To achieve immunity to hepatitis B in healthcare workers who failed to respond to intramuscular vaccination and boosters. Design: An open prospective study of intradermal vaccination with recombinant hepatitis B vaccine. Setting: A large community hospital in Connecticut. Participants: Healthcare workers including physicians, nurses, and laboratory workers. Results: Immunization with high-dose intradermal recombinant hepatitis B vaccine, given in up to four doses, achieved immunity in 88% of healthcare workers who had previously been nonimmune. Conclusions: We conclude that intradermal vaccination is efficacious in the majority of healthcare workers who failed to respond to intramuscular vaccine. Further studies, including randomized comparisons with intramuscular vaccine as well as studies of cell-mediated immunity, appear warrantedKeywords
This publication has 12 references indexed in Scilit:
- Intradermal hepatitis B vaccination in a 300-bed primary care hospital: Experience with a recombinant vaccine in a four-dose scheduleAmerican Journal of Infection Control, 1993
- Hepatitis B vaccine responsiveness in Connecticut public safety personnelPublished by American Medical Association (AMA) ,1993
- Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workersPublished by American Medical Association (AMA) ,1993
- Reversal of nonresponders and postexposure prophylaxis by intradermal hepatitis B vaccination in Japanese medical personnelPublished by American Medical Association (AMA) ,1991
- Immunogenicity of Low-Dose Intradermal Recombinant DNA Hepatitis B VaccineSouthern Medical Journal, 1991
- Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccinationVaccine, 1989
- Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccineJAMA, 1988
- Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen.The Journal of Experimental Medicine, 1988
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- Hepatitis B VaccineNew England Journal of Medicine, 1980